Fibromuscular Dysplasia: An Uncommon Cause of Secondary Hypertension

Journal of Clinical Hypertension

Volumn 8, Issue 12, 2006, Pages 894-898

  Prisant, L Michael ^a,b   Szerlip, Harold M ^a,b   Mulloy, Laura L ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b Section of Nephrology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME I; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; UNCLASSIFIED DRUG;

ALLELE; ANGIOPLASTY; ARTICLE; BLOOD PRESSURE REGULATION; CAUCASIAN; CLINICAL FEATURE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DELAYED DIAGNOSIS; DIAGNOSTIC TEST; DIASTOLIC BLOOD PRESSURE; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE COURSE; DISEASE DURATION; DNA POLYMORPHISM; ECHOGRAPHY; FAMILY HISTORY; FIBROMUSCULAR DYSPLASIA; FOLLOW UP; GENETIC PREDISPOSITION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY ANGIOGRAPHY; KIDNEY ARTERY STENOSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MOLECULAR PATHOLOGY; NEPHRECTOMY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; REPRODUCIBILITY; RESTENOSIS; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; GENETICS; RENAL ARTERY; REVIEW;

FIBROMUSCULAR DYSPLASIA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RENAL ARTERY;

EID: 34648873734     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1524-6175.2006.06021.x     Document Type: Article

References (40)

1. Moser M, Setaro JF. Clinical practice. Resistant or difficult-to-control hypertension. N Engl J Med. 2006;355:385–392.
2. Anderson GH Jr, Blakeman N, Streeten DH. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens. 1994;12:609–615.
3. Detection, evaluation, and treatment of renovascular hypertension. Final report. Working Group on Renovascular Hypertension. Arch Intern Med. 1987;147:820–829.
4. Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med. 2004;350:1862–1871.
5. Kincaid OW, Davis GD, Hallermann FJ, et al. Fibromuscular dysplasia of the renal arteries. Arteriographic features, classification, and observations on natural history of the disease. Am J Roentgenol Radium Ther Nucl Med. 1968;104:271–282.
6. Pannier-Moreau I, Grimbert P, Fiquet-Kempf B, et al. Possible familial origin of multifocal renal artery fibromuscular dysplasia. J Hypertens. 1997;15:1797–1801.
7. Lüscher TF, Lie JT, Stanson AW, et al. Arterial fibromuscular dysplasia. Mayo Clin Proc. 1987;62:931–952.
8. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001;344:431–442.
9. Pohl MA, Novick AC. Natural history of atherosclerotic and fibrous renal artery disease: clinical implications. Am J Kidney Dis. 1985;5:A120–A130.
10. Mounier-Vehier C, Lions C, Jaboureck O, et al. Parenchymal consequences of fibromuscular dysplasia renal artery stenosis. Am J Kidney Dis. 2002;40:1138–1145.
11. Carr AA, Prisant LM, Bottini PB. Evaluation and management of hypertensives for renovascular hypertension. In: Mandal AK, Jennette JC, eds. Diagnosis and Management of Renal Disease and Hypertension. 2nd ed. Durham, NC: Carolina Academic Press; 1994:389–409.
12. Sang CN, Whelton PK, Hamper UM, et al. Etiologic factors in renovascular fibromuscular dysplasia. A case-control study. Hypertension. 1989;14:472–479.
13. Rushton AR. The genetics of fibromuscular dysplasia. Arch Intern Med. 1980;140:233–236.
14. 1-antitrypsin gene polymorphisms are not associated with renal arterial fibromuscular dysplasia. J Hypertens. 2006;24:705–710.
15. Bofinger A, Hawley C, Fisher P, et al. Polymorphisms of the renin-angiotensin system in patients with multifocal renal arterial fibromuscular dysplasia. J Hum Hypertens. 2001;15:185–190.
16. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–1252.
17. Simon N, Franklin SS, Bleifer KH, et al. Clinical characteristics of renovascular hypertension. JAMA. 1972;220:1209–1218.
18. Goldman AG, Varady PD, Franklin SS. Body habitus and serum cholesterol in essential hypertension and renovascular hypertension. JAMA. 1972;221:378–383.
19. Turnbull JM. The rational clinical examination. Is listening for abdominal bruits useful in the evaluation of hypertension? JAMA. 1995;274:1299–1301.
20. Carr AA. Renovascular disease and high blood pressure. J Med Assoc Ga. 1975;64:272–277.
21. de Mendonca WC, Espat PA. Pheochromocytoma associated with arterial fibromuscular dysplasia. Am J Clin Pathol. 1981;75:749–754.
22. Vasbinder GB, Nelemans PJ, Kessels AG, et al. Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Ann Intern Med. 2001;135:401–411.
23. Vasbinder GB, Nelemans PJ, Kessels AG, et al. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med. 2004;141:674–682 [discussion 82].
24. Leiner T, de Haan MW, Nelemans PJ, et al. Contemporary imaging techniques for the diagnosis of renal artery stenosis. Eur Radiol. 2005;15:2219–2229.
25. Olin JW, Piedmonte MR, Young JR, et al. The utility of duplex ultrasound scanning of the renal arteries for diagnosing significant renal artery stenosis. Ann Intern Med. 1995;122:833–838.
26. Radermacher J, Chavan A, Bleck J, et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med. 2001;344:410–417.
27. Beregi JP, Louvegny S, Gautier C, et al. Fibromuscular dysplasia of the renal arteries: comparison of helical CT angiography and arteriography. AJR Am J Roentgenol. 1999;172:27–34.
28. Alhadad A, Mattiasson I, Ivancev K, et al. Revascularisation of renal artery stenosis caused by fibromuscular dysplasia: effects on blood pressure during 7-year follow-up are influenced by duration of hypertension and branch artery stenosis. J Hum Hypertens. 2005;19:761–767.
29. Leung DA, Hoffmann U, Pfammatter T, et al. Magnetic resonance angiography versus duplex sonography for diagnosing renovascular disease. Hypertension. 1999;33:726–731.
30. Tegtmeyer CJ, Selby JB, Hartwell GD, et al. Results and complications of angioplasty in fibromuscular disease. Circulation. 1991;83:I155–I161.
31. Gowda MS, Loeb AL, Crouse LJ, et al. Complementary roles of color-flow duplex imaging and intravascular ultrasound in the diagnosis of renal artery fibromuscular dysplasia: should renal arteriography serve as the “gold standard”? J Am Coll Cardiol. 2003;41:1305–1311.
32. Tegtmeyer CJ, Elson J, Glass TA, et al. Percutaneous transluminal angioplasty: the treatment of choice for renovascular hypertension due to fibromuscular dysplasia. Radiology. 1982;143:631–637.
33. Birrer M, Do DD, Mahler F, et al. Treatment of renal artery fibromuscular dysplasia with balloon angioplasty: a prospective follow-up study. Eur J Vasc Endovasc Surg. 2002;23:146–152.
34. Bonelli FS, McKusick MA, Textor SC, et al. Renal artery angioplasty: technical results and clinical outcome in 320 patients. Mayo Clin Proc. 1995;70:1041–1052.
35. Novick AC, Ziegelbaum M, Vidt DG, et al. Trends in surgical revascularization for renal artery disease. Ten years' experience. JAMA. 1987;257:498–501.
36. Bookstein JJ, Abrams HL, Buenger RE, et al. Radiologic aspects of renovascular hypertension. 3. Appraisal of arteriography. JAMA. 1972;221:368–374.
37. Foster JH, Maxwell MH, Franklin SS, et al. Renovascular occlusive disease. Results of operative treatment. JAMA. 1975;231:1043–1048.
38. Franklin SS, Young JD Jr, Maxwell MH, et al. Operative morbidity and mortality in renovascular disease. JAMA. 1975;231:1148–1153.
39. Reiher L, Pfeiffer T, Sandmann W. Long-term results after surgical reconstruction for renal artery fibromuscular dysplasia. Eur J Vasc Endovasc Surg. 2000;20:556–559.
40. Anderson CA, Hansen KJ, Benjamin ME, et al. Renal artery fibromuscular dysplasia: results of current surgical therapy. J Vasc Surg. 1995;22:207–215 [discussion 15–16].